GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KAINOS Laboratories Inc (TSE:4556) » Definitions » EBITDA Margin %

KAINOS Laboratories (TSE:4556) EBITDA Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is KAINOS Laboratories EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. KAINOS Laboratories's EBITDA for the three months ended in Sep. 2024 was 円0 Mil. KAINOS Laboratories's Revenue for the three months ended in Sep. 2024 was 円0 Mil. Therefore, KAINOS Laboratories's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.


KAINOS Laboratories EBITDA Margin % Historical Data

The historical data trend for KAINOS Laboratories's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KAINOS Laboratories EBITDA Margin % Chart

KAINOS Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.12 17.93 20.04 20.20 20.88

KAINOS Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.84 24.63 21.97 9.40 -

Competitive Comparison of KAINOS Laboratories's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's EBITDA Margin % falls into.


;
;

KAINOS Laboratories EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

KAINOS Laboratories's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1055.779/5056.463
=20.88 %

KAINOS Laboratories's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KAINOS Laboratories  (TSE:4556) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


KAINOS Laboratories EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of KAINOS Laboratories's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


KAINOS Laboratories Business Description

Traded in Other Exchanges
N/A
Address
38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.

KAINOS Laboratories Headlines

No Headlines